Molecular Hydrogen as an Adjuvant Therapy in Severe Lupus Serositis With Heart Failure: A Case Report on Immune Modulation and Fatigue Reduction
This case highlights the potential of molecular hydrogen therapy as an adjuvant treatment in SLE, with observed benefits in immune modulation and fatigue reduction. Further studies are warranted to elucidate its therapeutic role and applicability in autoimmune diseases.
Authors
- Yi‐Jung Ho (ORCID: https://orcid.org/0009-0006-3931-2302)
- SHAN-WEN LUI (ORCID: https://orcid.org/0009-0002-1151-6814)
- Hsiao-Chen Liu
- KUANG-YIH WANG
- Jeng‐Wei Lu (ORCID: https://orcid.org/0000-0003-2128-2046)
- Feng‐Cheng Liu (ORCID: https://orcid.org/0000-0003-1291-8946)
- YUN-TING LIN
- TING-YU HSIEH
Institutions
- University of Copenhagen (DK)
- Rigshospitalet (DK)
- National Defense Medical Center (TW)
Publication Details
- Journal
- In Vivo
- Published
- 2025-02-26
- DOI
- https://doi.org/10.21873/invivo.13924
- Citations
- 4
- Primary Topic
- Hydrogen's biological and therapeutic effects
- Type
- article
- Field-Weighted Citation Impact
- 8.03
Funders
- Tri-Service General Hospital
- National Science and Technology Council